TSX closed
Loading markets…

Advertisement

Stocks

A Week of Losses for Extendicare: What the Chart and the News Say

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:EXE.TO

Follow EXE

Photos provided by Pexels

Extendicare Inc experienced a significant decline this week, dropping 9.0%.

Extendicare Inc's stock fell by 9.0% this week, closing at C$26.31. This decline comes amidst a broader context of fluctuating performance, as the company has seen a 13.0% decrease over the past month and an overall increase of 30.77% year-to-date.

Advertisement

Extendicare Inc

EXE.TO

Full stock page →

EXE.TO

Extendicare Inc

Source:WealthAwesomeWealthAwesome
↓ $1.26 (-4.42%)
120 day period
$26.68$32.66$38.63Apr 20Jul 15Oct 8

Market cap

$2.59B

P/E

20.5x

Div. yield

1.84%

Div. / share

$0.51

52W high

$38.98

52W low

$14.21

1W change

-9.00%

Beta

1.07

Analyst Price Targets

Based on analyst covering EXE · as of Sep 17, 2026

📈

Wall Street analysts forecast EXE stock price to rise 46.4% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$39.83

+46.4% Upside

Current Price

C$27.20

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on EXE's historical volatility

HistoricalForecast68%95%
C$15.02C$19.97C$24.93C$29.88C$34.84C$39.79TodayJun 2Aug 6Oct 8Nov 20Jan 3Feb 15

30-Day Vol

32.2%

Annualized

90-Day Vol

31.8%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$22.75

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$25.63C$22.93 – C$28.64
60 trading daysC$24.15C$20.64 – C$28.26
90 trading daysC$22.75C$18.77 – C$27.58

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Investors should closely monitor Extendicare's stock as it remains below key moving averages and has shown recent volatility.

Stock Falls 9% This Week Amid Declining Performance

With a last close of C$26.31, Extendicare's stock is now down 13% over the past month and 9% this week.

Bull case

Analysts have set an average target price of C$39.83 for Extendicare, suggesting a potential upside of 51.4%. This indicates that there may be room for growth if the company can stabilize its performance.

Bear case

Currently, the stock price is significantly below both its 50-day average of C$31.29 and its 200-day average of C$29.56. This situation points to potential bearish momentum, which could concern investors looking for stability.

Stock Performance Overview

Advertisement

This week, Extendicare Inc's stock dropped by 9.0%, closing at C$26.31. The company's performance over the past month has also been challenging, with a total decrease of 13.0%. Year-to-date, however, Extendicare has seen an increase of 30.77%. The latest trading volume stood at 472,638 shares, which is approximately 0.90 times the 20-day average volume of 671,105 shares, indicating reduced trading activity during this period.

Technical Analysis

Extendicare's stock is currently trading significantly below its 50-day moving average of C$31.29, reflecting a decline of 15.9% from the current price. Additionally, it is also beneath its 200-day moving average of C$29.56, showing an 11.0% difference. The stock's price is currently within 49% of its 52-week range of C$14.21 to C$38.98, indicating that it is closer to the lower end of its historical price spectrum, which could be a concern for investors.

Market Outlook and Analyst Sentiment

Despite the recent decline, the average analyst target for Extendicare stands at C$39.83, implying a potential upside of 51.4%. The company's fundamentals show a P/E ratio of 20.45, which may be attractive to some investors. Extendicare has a profit margin of 6.1% and a return on equity (ROE) of 43.8%, highlighting its profitability. As the stock faces downward pressure, these fundamentals may play a critical role in investor sentiment moving forward.


Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: October 9, 2026
Last Updated: October 9, 2026

Core portfolio

Awesome Portfolio™

14.8% a year since 2017, against 9.7% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+14.8%

Awesome Portfolio™

+9.7%

S&P/TSX

+5.0 pp better a year

Total return

+254%

Awesome Portfolio™

+134%

S&P/TSX

+119 pp better than the TSX

2017-07-31 to 2026-09-29, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-29
-11.7%42.5%96.7%150.9%205.1%259.3%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement